323001 VU Introduction to Drug Discovery and Preclinical Drug Development - MPS1 (2018W)
Continuous assessment of course work
Labels
Vorbesprechung am 01.10.2018 14.00-17.00 Uhr in Raum 2D313.
Details
Language: English
Lecturers
Classes (iCal) - next class is marked with N
Die VO findet von 14.00-17.00 Uhr im Raum 2D313 statt.
Termine:
01.10.2018
02.10.2018
03.10.2018
04.10.2018
08.10.2018
09.10.2018
11.10.2018
12.10.2018
15.10.2018
16.10.2018
17.10.2018
18.10.2018
22.10.2018
- Monday 01.10. 14:00 - 17:00 Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II
- Tuesday 02.10. 14:00 - 17:00 Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II
- Wednesday 03.10. 14:00 - 17:00 Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II
- Thursday 04.10. 14:00 - 17:00 Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II
- Monday 08.10. 14:00 - 17:00 Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II
- Tuesday 09.10. 14:00 - 17:00 Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II
- Wednesday 10.10. 14:00 - 17:00 Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II
- Thursday 11.10. 14:00 - 17:00 Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II
- Friday 12.10. 14:00 - 17:00 Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II
- Monday 15.10. 14:00 - 17:00 Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II
- Tuesday 16.10. 14:00 - 17:00 Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II
- Wednesday 17.10. 14:00 - 17:00 Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II
- Thursday 18.10. 14:00 - 17:00 Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II
- Monday 22.10. 14:00 - 17:00 Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II
Information
Aims, contents and method of the course
The students will be introduced to basic principles in drug discovery. The course will consist of presentations given by the faculty, as well as presentations given by students, followed by round table discussions.
Assessment and permitted materials
There will be one written exam at the end of the course.
The grades will be deduced to 40% from the result in the written exam, to 30% from the quality of the oral presentations and 30 % from the active participation in the discussions during the course.
The grades will be deduced to 40% from the result in the written exam, to 30% from the quality of the oral presentations and 30 % from the active participation in the discussions during the course.
Minimum requirements and assessment criteria
The student should possess basic knowledge in principles of drug discovery. Topics will cover target identification and validation, structural biology, hit identification and validation, lead structure identification and optimization and hereby be able to understand and comprehensively and critically present original papers / projects /ideas to these topics.
Examination topics
All topics covered during the course.
Reading list
Some useful literature can be found in the following publications:
- Benjamin E. Blass: Basic Principles of Drug Discovery and Development (Academic Press, ISBN 978-0-12-411508-8)
- Raymond Hill: Drug Discovery and Development: Technology in Transition (Churchill Livingstone Elsevier, ISBN 976-0-7020-4299-7)
- Jeffrey Strovel et al.: Early Drug Discovery and Development Guidelines: For Academic Researchers, Collaborators, and Start-up Companies (https://www.ncbi.nlm.nih.gov/books/NBK92015/pdf/Bookshelf_NBK92015.pdf)
- Benjamin E. Blass: Basic Principles of Drug Discovery and Development (Academic Press, ISBN 978-0-12-411508-8)
- Raymond Hill: Drug Discovery and Development: Technology in Transition (Churchill Livingstone Elsevier, ISBN 976-0-7020-4299-7)
- Jeffrey Strovel et al.: Early Drug Discovery and Development Guidelines: For Academic Researchers, Collaborators, and Start-up Companies (https://www.ncbi.nlm.nih.gov/books/NBK92015/pdf/Bookshelf_NBK92015.pdf)
Association in the course directory
Last modified: Sa 02.04.2022 00:27